# Template-based eukaryotic genome editing directed by SviCas3

Preprint · Wang-Yu Tong, Yong Li, Shou-Dong Ye, An-Jing Wang, Yan-Yan Tang, Mei-Li Li, Zhong-Fan Yu, Ting-Ting Xia, Qing-Yang Liu, Si-Qi Zhu

- Archive id: arxiv:2305.05861
- Published: 2023-05-10
- arXiv: https://arxiv.org/abs/2305.05861
- Citations: 0
- Source URL: https://arxiv.org/abs/2305.05861
- PDF: https://arxiv.org/pdf/2305.05861
- Provenance: arxiv

## Abstract

RNA-guided gene editing based on the CRISPR-Cas system is currently the most effective genome editing technique. Here, we report that the SviCas3 from the subtype I-B-Svi Cas system in Streptomyces virginiae IBL14 is an RNA-guided and DNA-guided DNA endonuclease suitable for the HDR-directed gene and/or base editing of eukaryotic cell genomes. The genome editing efficiency of SviCas3 guided by DNA is no less than that of SviCas3 guided by RNA. In particular, t-DNA, as a template and a guide, does not require a proto-spacer-adjacent motif, demonstrating that CRISPR, as the basis for crRNA design, is not required for the SviCas3-mediated gene and base editing. This discovery will broaden our understanding of enzyme diversity in CRISPR-Cas systems, will provide important tools for the creation and modification of living things and the treatment of human genetic diseases, and will usher in a new era of DNA-guided gene editing and base editing.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [CRISPR & Gene-Editing Therapies](https://space-kitty.com/topics/gene-editing-therapies)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.